Interleukin-16 genetic polymorphisms in Guangxi Chinese with hepatitis B virus-related liver cirrhosis

被引:0
|
作者
Zhang, Xiaolian [1 ]
Tang, Wenjun [2 ]
Qin, Xue [1 ]
Li, Shan [1 ]
Liang, Dong [3 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Dept Educ,Key Lab Clin Lab Med Guangxi, Nanning, Guangxi, Peoples R China
[2] Guilin Med Univ, Affiliated Hosp, Dept Clin Lab, Guilin, Guangxi, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Med Equipment Dept, Nanning, Guangxi, Peoples R China
关键词
Interleukin-16; Polymorphisms; Liver cirrhosis; IL-16; GENE; ASSOCIATION; SUSCEPTIBILITY; RISK; CARCINOMA; DISEASE;
D O I
10.1007/s11033-023-08450-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundOur previous study has reported that interleukin-16 (IL-16) genetic polymorphisms are significantly related to chronic hepatitis B (CHB) and hepatitis B virus-related (HBV-related) hepatocellular carcinoma (HCC). As CHB, liver cirrhosis (LC), and HCC are development processes, this study aimed to determine genetic correlation of IL-16 polymorphisms with HBV-related LC in a Chinese population.MethodsIL-16 gene rs11556218, rs4072111, and rs4778889 polymorphism in 129 patients with HBV-related LC and 168 healthy individuals were genotyped via polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). PCR-RFLP results were verified by DNA sequencing.ResultsThe allelic and genotypic distributions of IL-16 rs11556218, rs4072111, and rs4778889 polymorphisms in HBV-related LC patients showed no significant difference from those in healthy controls. Furthermore, no relationship was observed between the haplotype distribution and susceptibility to HBV-related LC.ConclusionsThis work provided the first evidence that the IL-16 genetic polymorphisms may not be associated with HBV-related LC risk.
引用
收藏
页码:5247 / 5254
页数:8
相关论文
共 50 条
  • [31] Antiviral therapy of decompensated hepatitis B virus-related cirrhosis
    CHEN Guang-cheng
    YU Tao
    HUANG Kai-hong
    CHEN Qi-kui
    中华医学杂志(英文版), 2012, (02) : 373 - 377
  • [32] Interleukin-17A and interleukin-17F gene polymorphisms and hepatitis B virus-related hepatocellular carcinoma risk in a Chinese population
    Xi, Xue-E
    Liu, Yanqiong
    Lu, Yu
    Huang, Liying
    Qin, Xue
    Li, Shan
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 8
  • [33] Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis
    Fu-Kui Zhang Liver Research Center
    Hepatobiliary&PancreaticDiseasesInternational, 2006, (01) : 10 - 15
  • [34] Cardiac health in patients with hepatitis B virus-related cirrhosis
    Yuan, Wei
    Lu, Hong-Zhou
    Mei, Xue
    Zhang, Yu-Yi
    Zhang, Zheng-Guo
    Zou, Ying
    Wang, Jie-Fei
    Qian, Zhi-Ping
    Guo, Hong-Ying
    MEDICINE, 2019, 98 (13)
  • [35] Associations between single nucleotide polymorphisms of cytokines and hepatitis B virus-related liver cirrhosis: A case-control study
    Li, Yijun
    Zhou, Haowei
    Wu, Weikang
    Zhang, Wenhua
    Ye, Yancheng
    Jia, Wenling
    Liang, Chunhui
    Tang, Haitao
    Wang, Fengmei
    Shao, Zhongjun
    Yuan, Xiaojie
    Zhang, Weilu
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (09)
  • [36] Assessment of the Fecal Lactobacilli Population in Patients with Hepatitis B Virus-Related Decompensated Cirrhosis and Hepatitis B Cirrhosis Treated with Liver Transplant
    Wu, Zhong-Wen
    Lu, Hai-Feng
    Wu, Jianping
    Zuo, Jian
    Chen, Ping
    Sheng, Ji-Fang
    Zheng, Shu-Sen
    Li, Lan-Juan
    MICROBIAL ECOLOGY, 2012, 63 (04) : 929 - 937
  • [37] Assessment of the Fecal Lactobacilli Population in Patients with Hepatitis B Virus-Related Decompensated Cirrhosis and Hepatitis B Cirrhosis Treated with Liver Transplant
    Zhong-Wen Wu
    Hai-Feng Lu
    Jianping Wu
    Jian Zuo
    Ping Chen
    Ji-Fang Sheng
    Shu-Sen Zheng
    Lan-Juan Li
    Microbial Ecology, 2012, 63 : 929 - 937
  • [38] The association between TN FR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population
    Ma, Liping
    Chen, Siyuan
    Mao, Xiaohuan
    Lu, Yu
    Zhang, Xiaolian
    Lao, Xianjun
    Qin, Xue
    Li, Shan
    SCIENTIFIC REPORTS, 2018, 8
  • [39] Statins and Risk of Decompensation in Hepatitis B Virus-Related and Hepatitis C Virus-Related Cirrhosis: Methodological Issues REPLY
    Chang, Fu-Ming
    Wang, Yen-Po
    Lu, Ching-Liang
    HEPATOLOGY, 2018, 67 (03) : 1174 - 1175
  • [40] PROGNOSIS AND ITS RELATED FACTORS IN PATIENTS WITH HEPATITIS B VIRUS-RELATED LIVER CIRRHOSIS IN THE ANTIVIRAL ERA
    Kim, C. H.
    Seo, Y. S.
    Kim, J. H.
    Yim, H. J.
    Yeon, J. E.
    Byun, K. S.
    Kim, C. D.
    Ryu, H. S.
    Um, S. H.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S71 - S71